Coral Jayne Pepper

Mrs. Coral Jayne Pepper

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KBKaren Brown
Karen Brown
DTDespoina Theofanous
Despoina Theofanous
RBRobert G. Britton
Robert G. Britton
GAGrandezza Aburido
Grandezza Aburido
CPCoral Jayne Pepper
Coral Jayne Pepper
LHLynne Howells
Lynne Howells
Resveratrol has long been proposed as being beneficial to human health across multiple morbidities, yet there is currently no conclusive clinical evidence to advocate its recommendation in any healthcare setting. A large cohort with high-quality clinical data and clearly defined biomarkers or endpoints are required to draw meaningful conclusions. This systematic review compiles every clinical trial conducted using a defined dose of resveratrol in a purified form across multiple morbidities to highlight the current ‘state-of-play’ and knowledge gaps, informing future trial designs to facilitate the realisation of resveratrol’s potential benefits to human health. Over the last 20 years, there have been almost 200 studies evaluating resveratrol across at least 24 indications, including cancer, menopause symptoms, diabetes, metabolic syndrome, and cardiovascular disease. There are currently no consensus treatment regimens for any given condition or endpoint, beyond the fact that resveratrol is generally well-tolerated at a dose of up to 1 g/day. Additionally, resveratrol consistently reduces inflammatory markers and improves aspects of a dysregulated metabolism. In conclusion, over the last 20 years, the increasing weight of clinical evidence suggests resveratrol can benefit human health, but more large, high-quality clinical trials are required to transition this intriguing compound from health food shops to the clinic.

22 October 2019 in Annals of Surgery
Verified
Journal Article
Closed access
JHJohn S. M. Houghton
John S. M. Houghton
ANAndrew Nickinson
Andrew Nickinson
AMAlastair J. Morton
Alastair J. Morton
SNSarah Nduwayo
Sarah Nduwayo
CPCoral Jayne Pepper
Coral Jayne Pepper
RSRob D. Sayers
Rob D. Sayers
Objective: To describe and critique tools used to assess frailty in vascular surgery patients, and investigate its associations with patient factors and outcomes. Background: Increasing evidence shows negative impacts of frailty on outcomes in surgical patients, but little investigation of its associations with patient factors has been undertaken. Methods: Systematic review and meta-analysis of studies reporting frailty in vascular surgery patients (PROSPERO registration: CRD42018116253) searching Medline, Embase, CINAHL, PsycINFO, and Scopus. Quality of studies was assessed using Newcastle–Ottawa scores (NOS) and quality of evidence using Grading of Recommendations Assessment, Development, and Evaluation criteria. Associations of frailty with patient factors were investigated by difference in means (MD) or expressed as risk ratios (RRs), and associations with outcomes expressed as odds ratios (ORs) or hazard ratios (HRs). Data were pooled using random-effects models. Results: Fifty-three studies were included in the review and only 8 (15%) were both good quality (NOS ≥ 7) and used a well-validated frailty measure. Eighteen studies (62,976 patients) provided data for the meta-analysis. Frailty was associated with increased age [MD 4.05 years; 95% confidence interval (CI) 3.35, 4.75], female sex (RR 1.32; 95% CI 1.14, 1.54), and lower body mass index (MD −1.81; 95% CI −2.94, −0.68). Frailty was associated with 30-day mortality [adjusted OR (AOR) 2.77; 95% CI 2.01–3.81), postoperative complications (AOR 2.16; 95% CI 1.55, 3.02), and long-term mortality (HR 1.85; 95% CI 1.31, 2.62). Sarcopenia was not associated with any outcomes. Conclusion: Frailty, but not sarcopenia, is associated with worse outcomes in vascular surgery patients. Well-validated frailty assessment tools should be preferred clinically, and in future research.

1 February 2020 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
ANAndrew Nickinson
Andrew Nickinson
BBBernadeta Bridgwood
Bernadeta Bridgwood
JHJohn S.M. Houghton
John S.M. Houghton
SNSarah Nduwayo
Sarah Nduwayo
CPCoral Jayne Pepper
Coral Jayne Pepper
RSRob D. Sayers
Rob D. Sayers

25 August 2022 in EP Europace
Verified
Journal Article
Closed access
PDF file
JBJoseph Barker
Joseph Barker
XLXin Li
Xin Li
SKSarah Khavandi
Sarah Khavandi
DKDavid Koeckerling
David Koeckerling
AMAkash Mavilakandy
Akash Mavilakandy
GNG. André Andre Ng
G. André Andre Ng
Most patients who receive implantable cardioverter defibrillators (ICDs) for primary prevention do not receive therapy during the lifespan of the ICD, whilst up to 50% of sudden cardiac death (SCD) occur in individuals who are considered low risk by conventional criteria. Machine learning offers a novel approach to risk stratification for ICD assignment. Systematic search was performed in MEDLINE, Embase, Emcare, CINAHL, Cochrane Library, OpenGrey, MedrXiv, arXiv, Scopus, and Web of Science. Studies modelling SCD risk prediction within days to years using machine learning were eligible for inclusion. Transparency and quality of reporting (TRIPOD) and risk of bias (PROBAST) were assessed. A total of 4356 studies were screened with 11 meeting the inclusion criteria with heterogeneous populations, methods, and outcome measures preventing meta-analysis. The study size ranged from 122 to 124 097 participants. Input data sources included demographic, clinical, electrocardiogram, electrophysiological, imaging, and genetic data ranging from 4 to 72 variables per model. The most common outcome metric reported was the area under the receiver operator characteristic (n = 7) ranging between 0.71 and 0.96. In six studies comparing machine learning models and regression, machine learning improved performance in five. No studies adhered to a reporting standard. Five of the papers were at high risk of bias. Machine learning for SCD prediction has been under-applied and incorrectly implemented but is ripe for future investigation. It may have some incremental utility in predicting SCD over traditional models. The development of reporting standards for machine learning is required to improve the quality of evidence reporting in the field.

30 January 2020 in Vascular Medicine
Verified
Journal Article
Closed access
PDF file
BBBernadeta M Bridgwood
Bernadeta M Bridgwood
ANAndrew Nickinson
Andrew Nickinson
JHJohn Sm Houghton
John Sm Houghton
CPCoral Jayne Pepper
Coral Jayne Pepper
RSRob D Sayers
Rob D Sayers
This systematic review evaluated the knowledge and awareness of peripheral artery disease (PAD) within the general public (including patients with peripheral vascular disease), nonspecialist healthcare professionals (nsHCP), and trainees (medical students and trainee doctors). Relevant articles were identified from electronic databases using key search terms: ‘peripheral artery disease’; ‘limb ischaemia’; ‘intermittent claudication’; ‘knowledge’; ‘understanding’; ‘public’; ‘medical professional’. The heterogeneous results were described narratively. A lack of knowledge and understanding of PAD (disease awareness) were identified in all groups. Among nsHCPs, factors which affect knowledge include the level of training, early clinical exposure and the presence of family members with cardiovascular/vascular disease. Within the general public, knowledge and awareness was improved if a family member/friend had a diagnosis, or following a patient-centred consultation with any HCP. Public campaigns are proven effective in improving disease knowledge/awareness in conditions such as stroke alongside sustained patient education. These may provide future avenues to improve PAD knowledge and awareness, in order to effectively manage risk factors and minimise delayed or missed diagnosis of PAD. (PROSPERO registration number: CRD42018117304)

1 April 2021 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
JHJohn S.M. Houghton
John S.M. Houghton
ANAndrew T.O. Nickinson
Andrew T.O. Nickinson
BBBernadeta Bridgwood
Bernadeta Bridgwood
SNSarah Nduwayo
Sarah Nduwayo
CPCoral Jayne Pepper
Coral Jayne Pepper
RSRob D. Sayers
Rob D. Sayers